The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper

The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paper / Fiorino, G; Girolomoni, G; Lapadula, G; Orlando, A; Danese, S; Olivieri, I. - In: AUTOIMMUNITY REVIEWS. - ISSN 1568-9972. - 13:7(2014), pp. 751-755. [10.1016/j.autrev.2014.02.004]